Evidence map›Paper›PMID 21934552›Full record

ArticlePancreas2012

RNA interference characterization of proteins discovered by proteomic analysis of pancreatic cancer reveals function in cell growth and survival.

Candy N Lee, Jenny L Heidbrink, Katherine McKinnon, Victoria Bushman, Henrik Olsen, William FitzHugh, Aiqun Li, Karen Van Orden, Tao He, Steven M Ruben and 1 more

Open access · greenAbstract read
In one paragraph

Article in Pancreas, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 20 citations in OpenAlex.

  1. Dynamic profiling of medulloblastoma surfaceome.Acta neuropathologica communications · 2023
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Inhibition of pancreatic tumoral cells by snake venom disintegrins.Toxicon : official journal of the International Society on Toxinology · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Candy N LeeDepartment of Protein Therapeutic, Celera, Rockville, MD 20850, USA. candynlee@gmail.com
Jenny L Heidbrink
Katherine McKinnon
Victoria Bushman
Henrik Olsen
William FitzHugh
Aiqun Li
Karen Van Orden
Tao He
Steven M Ruben
Paul A Moore

Funding

CCR VB FACS COREZICBC010936 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI MCKINNON, KATHERINE · 2009 to 2025
$10.9M
Intramural NIH HHS ZIC BC010936
6 · The paper itself

Abstract

objectivesThere is a clear need for better therapeutics and diagnostics for pancreatic cancer. We aimed to discover plasma membrane-associated proteins overexpressed in pancreatic cancer using quantitative proteomics and apply RNA interference (RNAi) to uncover proteins associated with cancer cell survival.

methodsCell surface glycoproteins from 5 pancreatic cancer cell lines were isolated, and differential analyses were performed using mass spectrometry and the "normoid" cell line Hs766T as the comparator. For validation, immunohistochemistry was performed on tissues from 10 independent patients and 2 normal donors. Correlation of protein and mRNA expression level was determined, and functional activity characterized using RNAi.

resultsIntegrin β6, CD46, tissue factor, and a novel protein, chromosome 14 open reading frame 1, were identified as overexpressed on pancreatic cancer cell lines. Immunohistochemistry demonstrated the 4 targets were overexpressed in 20% to 70% of primary pancreatic tumor specimens. Small interfering RNA knockdown resulted in a reduction of cellular proliferation by inhibiting DNA synthesis, blocking S-phase progression or induction of apoptosis.

conclusionsBy combining a mass spectrometry identification platform and an RNAi validation platform, we have identified a panel of cell surface glycoproteins that not only are overexpressed, but also play a functional role in pancreatic tumor cell survival.

Indexed as

Cell ProliferationRNA InterferenceCell Line, TumorCell SurvivalFlow CytometryGene Expression Regulation, NeoplasticHumansImmunohistochemistryIntegrin beta ChainsMembrane Cofactor ProteinMembrane GlycoproteinsMembrane ProteinsNeoplasm ProteinsPancreatic NeoplasmsProteomicsReverse Transcriptase Polymerase Chain ReactionCD46 protein, humanERG28 protein, humanintegrin beta6Integrin beta ChainsMembrane Cofactor ProteinMembrane GlycoproteinsMembrane ProteinsNeoplasm ProteinsThromboplastin

Identifiers

PMID21934552
PMCPMC7457147
OpenAlexW1991671556

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.